“A Double-Masked, Randomized Study To Investigate The Safety And Efficacy Of Daclizumab To Treat The Ocular Complications Related To Behçet's Disease”. Ocul Immunol Inflamm 15. Ocul Immunol Inflamm: 63-70. http://www.ncbi.nlm.nih.gov/pubmed/17558830.
. 2007. “High-Dose Daclizumab For The Treatment Of Juvenile Idiopathic Arthritis-Associated Active Anterior Uveitis”. Am J Ophthalmol 148. Am J Ophthalmol: 696-703.e1. http://www.ncbi.nlm.nih.gov/pubmed?term=19664754.
. 2009. “Infliximab For The Treatment Of Active Scleritis”. Can J Ophthalmol 44. Can J Ophthalmol: e9-e12. http://www.ncbi.nlm.nih.gov/pubmed/19506593.
. 2009.